PTEN and cancer: We found that there were not significant changes in both miR-92b-3p (Supplementary Fig. S3C) and PTEN (Supplementary Fig. S3D) levels in SMMC-7721, PANC-1, HepG2, H1299, and LNCaP under treatment with DCA, which suggested that this pathway was not affected in these cancer cell lines by DCA.